Finance
Scientists at the Indian Institute of Science (IISc) are said to have found a novel approach for detecting and destroying cancer cells in their early stages, which could be a huge breakthrough in cancer research.
The IISc scientists have presented a revolutionary method for cancer treatment that has the ability to detect and kill lung and cervical cancer cells in their early stages, which might be a huge step towards a cancer-free world.
The researchers exploited the anti-cancerous characteristics of hybrid gold and copper sulphide nanoparticles to target malignancy that had progressed to form a solid tumor mass in the body, according to media.
The nanoparticles, according to the researchers, are rich in photothermal, oxidative stress, and photoacoustic properties and have a high cancer detection rate when combined. The scientists exposed cancer cells acquired from cell lines to infrared (IR) light at frequencies of 960 nanometres (imaging) and 1,064nm (photothermal research) as part of the experiment.
The study produced astounding results because the approach was capable of not only detecting but also killing dangerous cancer cells. “In addition to a high detection rate, the observed cancer killing rate was around 25%,” stated Jaya Prakash, Assistant Professor at IIS’ Department of Instrumentation and Applied Physics (IAP).
The researchers also stated that nanoparticles could aid in the diagnosis and possibly eradication of other types of cancer.
Prakash is one of the paper’s authors, which was published in the journal ACS Applied Nano Materials.
Cancer remains one of the most lethal diseases in the world, killing millions in both poor and developed countries.
According to a report published in the Bio Medical Central Journal in May 2022, cancer cases in India are anticipated to rise to 29.8 million by 2025. According to the study, North and Northeast India will suffer the brunt of the increase in cancer rates, with seven forms of cancer accounting for more than 40% of all cancer cases in India viz. lung (10.6%), breast (10.5%), oesophagus (5.8%), mouth (5.7%), stomach (5.2%), liver (4.6%), and cervix uteri (4.3%).
Source:In
